Cargando…
Docking-based virtual screening studies aiming at the covalent inhibition of SARS-CoV-2 M(Pro) by targeting the cysteine 145
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 which has infected millions of people worldwide. The main protease of SARS-CoV-2 (M(Pro)) has been recognized as a key target for the development of antiviral compounds. Taking advantage of the X-ray cry...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896498/ https://www.ncbi.nlm.nih.gov/pubmed/33677227 http://dx.doi.org/10.1016/j.compbiolchem.2021.107463 |